Ford H C, Lim W C, Crooke M J
Clin Chim Acta. 1987 Jul 15;166(2-3):317-21. doi: 10.1016/0009-8981(87)90435-9.
The severity, prevalence and pathogenesis of abnormalities of carbohydrate metabolism in hyperthyroidism are incompletely defined. The extent of glycosylation of proteins provides an objective, retrospective index of glycemic control. We have measured the percent hemoglobin A1, random plasma glucose level and serum concentrations of fructosamine, total protein and albumin in hyperthyroid and euthyroid subjects attending a hospital-based thyroid clinic. A significant (p = 0.002) increase in the mean value for hemoglobin A1 and a significant (p = 0.0003) decrease in the mean values for fructosamine were found in the hyperthyroid group. The lower mean fructosamine value in the hyperthyroid group was attributed to a concomitant decline in the mean albumin concentration (p = 0.001). The mean value for glucose tended to be higher in the hyperthyroid group, but the difference did not reach significance at the 0.05 level (p = 0.09). The finding of a higher mean hemoglobin A1 concentration in hyperthyroid patients compared to euthyroid subjects is new evidence for a persistent abnormality in glycemic regulation in most thyrotoxic patients.
甲状腺功能亢进症中碳水化合物代谢异常的严重程度、患病率及发病机制尚未完全明确。蛋白质糖基化程度可提供血糖控制的客观回顾性指标。我们对一家医院甲状腺门诊的甲状腺功能亢进患者及甲状腺功能正常患者测定了糖化血红蛋白A1百分比、随机血糖水平以及血清果糖胺、总蛋白和白蛋白浓度。甲状腺功能亢进组的糖化血红蛋白A1平均值显著升高(p = 0.002),果糖胺平均值显著降低(p = 0.0003)。甲状腺功能亢进组果糖胺平均值较低归因于白蛋白平均浓度同时下降(p = 0.001)。甲状腺功能亢进组血糖平均值倾向于更高,但在0.05水平差异无统计学意义(p = 0.09)。与甲状腺功能正常的受试者相比,甲状腺功能亢进患者糖化血红蛋白A1平均浓度更高这一发现,是大多数甲状腺毒症患者血糖调节持续异常的新证据。